AIROLDI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 13.722
EU - Europa 8.997
AS - Asia 3.226
SA - Sud America 309
AF - Africa 44
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 8
Totale 26.333
Nazione #
US - Stati Uniti d'America 13.416
IT - Italia 2.444
DE - Germania 1.811
SG - Singapore 1.122
CN - Cina 1.014
RU - Federazione Russa 880
SE - Svezia 803
IE - Irlanda 562
PL - Polonia 493
UA - Ucraina 403
DK - Danimarca 359
GB - Regno Unito 345
HK - Hong Kong 280
CA - Canada 278
FR - Francia 275
VN - Vietnam 267
BR - Brasile 249
FI - Finlandia 150
IN - India 148
AT - Austria 135
ID - Indonesia 99
NL - Olanda 87
TR - Turchia 80
BE - Belgio 44
ES - Italia 43
JP - Giappone 43
RO - Romania 34
CH - Svizzera 32
PK - Pakistan 32
CZ - Repubblica Ceca 24
TW - Taiwan 21
PT - Portogallo 20
AU - Australia 19
AR - Argentina 18
IR - Iran 18
KR - Corea 15
EG - Egitto 14
MX - Messico 13
PH - Filippine 13
ZA - Sudafrica 13
BD - Bangladesh 11
GR - Grecia 11
PE - Perù 11
CL - Cile 10
UZ - Uzbekistan 9
CO - Colombia 8
EU - Europa 8
IQ - Iraq 8
NZ - Nuova Zelanda 8
BY - Bielorussia 6
MA - Marocco 6
VE - Venezuela 6
AZ - Azerbaigian 5
CR - Costa Rica 5
HU - Ungheria 5
JO - Giordania 5
EC - Ecuador 4
IL - Israele 4
LV - Lettonia 4
MY - Malesia 4
RS - Serbia 4
SV - El Salvador 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CY - Cipro 3
DZ - Algeria 3
EE - Estonia 3
LT - Lituania 3
LU - Lussemburgo 3
SA - Arabia Saudita 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HR - Croazia 2
LB - Libano 2
NO - Norvegia 2
PA - Panama 2
PY - Paraguay 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MC - Monaco 1
ME - Montenegro 1
OM - Oman 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 26.331
Città #
Ann Arbor 4.738
Frankfurt am Main 1.182
Woodbridge 1.000
Milan 953
Wilmington 918
Fairfield 846
Chandler 763
Singapore 748
Houston 562
Ashburn 548
Dublin 540
Kraków 476
Jacksonville 396
Seattle 373
Dearborn 289
Cambridge 280
Santa Clara 275
Hong Kong 274
New York 242
Princeton 196
Dong Ket 170
Beijing 160
Nanjing 129
Guangzhou 118
Vienna 118
Shanghai 112
Lawrence 87
Toronto 87
Jakarta 82
Altamura 78
Helsinki 66
Boardman 64
Montréal 64
Rome 64
Lachine 63
Hangzhou 60
San Diego 52
Los Angeles 50
Council Bluffs 47
Nanchang 43
Brussels 42
Ottawa 39
Fremont 38
Moscow 38
Andover 36
Grafing 36
Tianjin 36
Shenyang 31
Brescia 29
Hebei 28
Changsha 27
Florence 26
Desio 24
Jinan 24
London 24
Cinisello Balsamo 23
Hyderabad 23
Pune 22
Falls Church 21
Jiaxing 21
Monza 20
Redmond 20
Chicago 19
Padova 19
Dallas 18
Norwalk 18
Auburn Hills 17
Pioltello 17
Zhengzhou 17
Düsseldorf 16
São Paulo 16
Caivano 15
Nuremberg 15
Sacramento 15
Bienno 14
Como 14
Genoa 14
Kunming 14
Munich 14
Paris 14
Parma 14
Washington 14
Edmonton 13
Huizen 13
Kiev 13
Naples 13
Taipei 13
Torino 13
Turin 13
Verona 13
Faisalabad 12
Hanoi 12
Iasi 12
Ningbo 12
Roztoky 12
Bari 11
Caserta 11
Nürnberg 11
Seregno 11
Zurich 11
Totale 18.474
Nome #
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 639
Coffee variety, origin and extraction procedure: Implications for coffee beneficial effects on human health 608
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 590
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 529
Green coffee extract enhances oxidative stress resistance and delays aging in Caenorhabditis elegans 523
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 506
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 495
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 487
Natural compounds in cancer prevention: effects of coffee extracts and their main polyphenolic component 5-CQA on oncogenic Ras proteins 463
Methacycline displays a strong efficacy in reducing toxicity in a SCA3 Caenorhabditis elegans model 454
Sugar-derived Ras inhibitors: group epitope mapping by NMR spectroscopy and biological evaluation 444
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 436
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 433
Re LPS biogenetic pathway: Enzyme characterisation and synthetic efforts towards inhibitors 410
Glycoconjugates in cancer therapy 409
Studies on the mechanism of action of a new class of inhibitors of Ras activation 398
Glycan carriers as glycotools for medicinal chemistry applications 388
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 385
Nuclear Magnetic Resonance as an Attractive Resource for Monitoring Surveillance Candidates of Acute and Chronic Lung Disorders 357
Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent toxicity in neural cells and Caenorhabditis elegans animal model 351
bioNMR-based identification of natural anti-Aβ compounds in Peucedanum ostruthium 328
Flavonoids in the treatment of alzheimer’s and other neurodegenerative diseases 324
Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin 320
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis 319
Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide 290
Flavonoids and their glycosides as anti-amyloidogenic compounds: Aβ1-42 interaction studies to gain new insights on their potential for Alzheimer's disease prevention and therapy 288
Effectiveness of Vigna unguiculata seed extracts in preventing colorectal cancer 283
From cancer metabolism to new biomarkers and drug targets 277
Methionine supplementation stimulates mitochondrial respiration 275
On-cell Saturation Transfer Difference NMR study of Bombesin binding to GRP receptor 268
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: insights on cocoa’s anti-amyloidogenic activity 265
Versatile and Efficient Targeting Using a Single Nanoparticulate Platform and its Application to Cancer and Alzheimer's Disease 262
Enhanced amino acid utilization sustains growth of cells lacking Snf1/AMPK 255
Arabinose 5-phosphate isomerase as a target for antibacterial design: studies with substrate analogues and inhibitors 254
1H NMR to Evaluate the Metabolome of Bronchoalveolar Lavage Fluid (BALf) in Bronchiolitis Obliterans Syndrome (BOS): Toward the Development of a New Approach for Biomarker Identification 251
Green and Roasted Coffee Extracts Inhibit Interferon-β Release in LPS-Stimulated Human Macrophages 249
Phosphonate Analogues of Arabinose 5-Phosphate: Putative Ligands for Arabinose 5-Phosphate Isomerases 247
NMR analysis of budding yeast metabolomics: A rapid method for sample preparation 246
Nanoliposomes presenting on surface a cis-glycofused benzopyran compound display binding affinity and aggregation inhibition ability towards Amyloid b1-42 peptide 245
Targeting bacterial biofilm: a new LecA multivalent ligand with inhibitory activity 244
New targets for antibacterial design: Kdo biosynthesis and LPS machinery transport to the cell surface 243
Structural modifications of cis-glycofused benzopyran compounds and their influence on the binding to amyloid-β peptide 240
How Epigallocatechin-3-gallate and Tetracycline Interact with the Josephin Domain of Ataxin-3 and Alter Its Aggregation Mode 240
Natural glycoconjugates with antitumor activity 239
Curcumin derivatives as new ligands of Aβ peptides 239
Metabolomic profiling of beers: Combining 1H NMR spectroscopy and chemometric approaches to discriminate craft and industrial products 237
Carbohydrate Mimetics and Scaffolds: Sweet Spots in Medicinal Chemistry 235
Synthesis and biological evaluation of a small library of nojirimycin derived bicyclic iminosugars 234
Cis-Glyco-Fused Benzopyran Derivatives as Hit Compounds for the Development of Therapeutic and Diagnostic Tools against Neurodegenerative Diseases 234
Synthesis and biological evaluation of arabinose 5-phosphate mimics modified at position five 231
The Kdo biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and developmen 230
Towards a universal approach based on omics technologies for the quality control of food 228
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 224
Targeting Bacterial Membranes: NMR Characterization of Substrate Recognition and Binding Requirements of D-arabinose 5P Isomerase, a key enzyme in the biosynthesis of LPS 222
Carbohyrate scaffolds in chemical genetic studies 221
1H NMR to Explore the Metabolome of Exhaled Breath Condensate in α1-Antitrypsin Deficient Patients: A Pilot Study 221
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 212
Fructose-Based Proline Analogues: Exploring the Prolyl trans/cis-Amide Rotamer Population in Model Peptides 210
Exploiting the Therapeutic Potential of 8-β-d-Glucopyranosylgenistein: Synthesis, Antidiabetic Activity, and Molecular Interaction with Islet Amyloid Polypeptide and Amyloid β-Peptide (1-42) 208
Solid-phase supported mimic of GDP-l-galactose 206
Curcumin derivatives: Aβ-ligands as potential diagnostic and therapeutic tools for alzheimer's disease 206
NMR Molecular Recognition Studies for the Elucidation of Protein and Nucleic Acid Structure and Function 206
The Molecular Assembly of Amyloid Aβ Controls Its Neurotoxicity and Binding to Cellular Proteins 203
Pyrrolo[2,1-c][1,4]benzodiazepine as a scaffold for the design and synthesis of anti-tumour drugs 202
Antimicrobial peptides: Insights into membrane permeabilization, lipopolysaccharide fragmentation and application in plant disease control 198
Fluorinated Arabinose-5-Phosphate Analogues as Potential Antibactericals 197
Targeting Bacterial Membranes: Identification of Pseudomonas aeruginosaD-Arabinose-5P Isomerase and NMR Characterisation of its Substrate Recognition and Binding Properties 189
On-cell Saturation Transfer Difference NMR for the identification of FimH ligands and inhibitors 181
Development of new potential antitumor drugs based on Ras protein inhibition 179
Natural Compounds against Neurodegenerative Diseases: Molecular Characterization of the Interaction of Catechins from Green Tea with Aβ1-42, PrP106-126, and Ataxin-3 Oligomers 176
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 175
Fluorescent amyloid β-peptide ligand derivatives as potential diagnostic tools for Alzheimer’s disease 173
Sugar-Based Enantiomeric and Conformationally Constrained Pyrrolo[2,1-c][1,4]-Benzodiazepines as Potential GABAALigands 172
NMR Protein-Ligand Interaction Studies under Non-Homogeneous Conditions for Biomaterial Generation: A Model For Artificial Lectin-Carbohydrate Recognition 170
Cis-glyco-fused benzopyran compounds as new amyloid β peptide ligands 169
Synthesis of 3-Deoxy-D-threopentofuranose 5-Phosphate, a Substrate of Arabinose 5-Phosphate Isomerase 168
Tetracycline prevents Aβ oligomer toxicity through an atipical supramolecular interaction 168
Global Scientific Challenges: Perspectives from Young Scientists 167
Performance Assessment in Fingerprinting and Multi Component Quantitative NMR Analyses 164
New C-glycosylpolyphenol antidiabetic agents, effect on glucose tolerance and interaction with beta-amyloid. Therapeutic applications of the synthesized agent(s) and of Genista tenera ethyl acetate extracts containing some of those agents 161
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders 160
Cell-Free and In Vivo Characterization of the Inhibitory Activity of Lavado Cocoa Flavanols on the Amyloid Protein Ataxin-3: Toward New Approaches against Spinocerebellar Ataxia Type 3 159
New tricyclic compounds, process for their manufacture and their use as ligands of beta-alyloid peptides 154
A Contribution to the Harmonization of Non-targeted NMR Methods for Data-Driven Food Authenticity Assessment 154
On-cell NMR screening of multivalent ligands for bacterial targeting 152
Cheese-whey permeate improves the fitness of Escherichia coli cells during recombinant protein production 152
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, in Vitro, and in Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 150
Aβ Monomers, Oligomers and Fibrils: Structural Features 150
Aminated Sugars, Synthesis, and Biological Activity 149
Synthesis of C- and S-Glycosides 149
Natural Compounds against Alzheimer´s Disease: Molecular Recognition of Aβ1–42 Peptide by Salvia sclareoides Extract and its Major Component, Rosmarinic Acid, as Investigated by NMR 148
null 146
Synthesis of C- and S-Glycosides 146
Phytotoxicity, nematicidal activity and chemical constituents of Peucedanum ostruthium (L.) W.D.J.Koch (Apiaceae) 145
Anticancer Effects of Wild Mountain Mentha longifolia Extract in Adrenocortical Tumor Cell Models 142
Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi β amiloidi (Aβ) 141
Saturation Transfer Difference NMR Experiments of Membrane Proteins in Living Cells under HR-MAS Conditions: the Interaction of the SGLT1 Co-transporter with Its Ligands 139
A community-built calibration system: The case study of quantification of metabolites in grape juice by qNMR spectroscopy 124
Cross‐linking effects dictate the preference of galectins to bind lacnac‐decorated hpma copolymers 114
Different phytotoxic effect of Lolium multiflorum Lam. leaves against Echinochloa oryzoides (Ard.) Fritsch and Oriza sativa L 113
Totale 25.860
Categoria #
all - tutte 81.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.069


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020865 0 0 0 0 0 0 0 0 0 393 293 179
2020/20214.409 239 182 370 416 318 376 362 404 375 494 294 579
2021/20223.283 308 342 310 309 161 271 222 154 283 246 273 404
2022/20233.885 498 944 488 370 326 514 127 195 199 57 99 68
2023/20242.424 104 119 158 188 269 483 376 131 181 68 99 248
2024/20254.336 282 582 519 308 425 274 279 230 594 843 0 0
Totale 27.372